黄斑微动脉瘤与慢性病和可推的糖尿病视网膜病变中的深毛细血管缺血有关
Shinji Kakihara1, Kallista Zhuang1, Anna Busza1
1Department of Ophthalmology, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, United States.
Investigative ophthalmology & visual science
|December 1, 2025
概括
在可转移性糖尿病视网膜病变 (refDR) 中,斑点小动脉瘤 (MA) 与慢性病 (CKD) 和减少深毛细血管血管长度密度有关. 较高的MA计数可能表明全身微血管疾病.
科学领域:
- 眼科医生 眼科 眼科
- 腎臟病學 (nephrology) 是一種醫學.
- 糖尿病视网膜病变研究研究
背景情况:
- 糖尿病视网膜病变 (DR) 是导致视力丧失的主要原因.
- 斑点微动脉瘤 (MAs) 是DR的早期症状.
- 导致MA发展的系统性因素需要进一步研究.
研究的目的:
- 在可转移性糖尿病视网膜病变 (refDR) 患者中确定与黄斑微动脉瘤 (MAs) 相关的视网膜和全身因素.
- 探索MA计数作为系统性微血管疾病生物标志物的潜力.
主要方法:
- 光学连贯断层扫描血管造影 (OCTA) 和超广场光素血管造影用于分析来自65名refDR患者的83只眼睛.
- 关键指标包括黄斑MA计数,非 perfusion 指数 (NPI) 和深毛细管 (VLD-DCP) 中的血管长度密度.
- 慢性病 (CKD) 的定义是估计的膜过率. 使用了线性混合模型和ROC分析.
主要成果:
- 在单变量分析中,黄斑MA计数与CKD,NPI和OCTA参数显著相关.
- 在多变量模型中,CKD和减少的VLD-DCP独立地与更高的MA数量相关 (P = 0.003-0.013).
- 14个黄斑MA的值显示了检测CKD的良好诊断性能 (AUC = 0.755).
结论:
- 慢性病和减少的VLD-DCP独立地与refDR中黄斑MA数量的增加有关.
- 黄斑MA计数可以作为糖尿病患者全身微血管疾病的潜在指标.
- 进一步的研究可以探索MA计数用于风险分层和监测refDR中的系统性并发症.
相关概念视频
01:20Renal Corpuscle
6.8K
The glomerulus and Bowman's capsule are two essential components of the nephron, which is the functional unit of the kidney. These microscopic structures play a critical role in the process of blood filtration to produce urine.
Glomerulus: Structure and Function
The glomerulus is a tiny, intricate network of capillaries located at the beginning of the nephron. It's enveloped by the Bowman's capsule and receives its blood supply from an afferent arteriole, which divides into numerous...
Glomerulus: Structure and Function
The glomerulus is a tiny, intricate network of capillaries located at the beginning of the nephron. It's enveloped by the Bowman's capsule and receives its blood supply from an afferent arteriole, which divides into numerous...
6.8K
01:25Chronic Kidney Disease I: Introduction
545
Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
545
01:24Chronic Kidney Disease II: Clinical Manifestations
529
Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
529